Table 2

Facilities which reported medicine is not available today

No (%) of facilities reporting medicine ‘not available today’*
HIC 2HIC 1UMCLMCLIC
Total no of facilitiesn=14n=5n=15n=16n=8
SIOP core
Asparaginase injection4/13 (31)0/54/15 (27)1/13 (8)0/7
Bleomycin injection2/13 (15)0/53/15 (20)4/14 (29)0/7
Carboplatin injection1/14 (7)0/51/15 (7)2/13 (15)1/7 (14)
Cisplatin injection1/14 (7)0/51/15 (7)3/13 (23)0/6
Cyclophosphamide tablet1/12 (8)0/34/12 (33)4/9 (44)1/6 (17)
Cyclophosphamide injection1/14 (7)0/52/15 (13)1/13 (8)0/7
Cytarabine injection1/14 (7)0/50/154/13 (31)1/7 (14)
Dacarbazine injection1/12 (8)0/53/15 (20)4/9 (44)0/6
Dactinomycin injection1/14 (7)0/52/15 (13)2/12 (17)1/7 (14)
Daunorubicin injection1/14 (7)0/52/13 (15)7/11 (64)1/5 (20)
Doxorubicin injection1/14 (7)0/51/15 (7)3/13 (23)0/7
Etoposide capsule2/12 (17)0/25/10 (50)4/5 (80)1/3 (33)
Etoposide injection1/14 (7)0/51/15 (7)2/14 (14)0/7
Hydroxycarbamide tablet/capsule0/100/33/10 (30)0/70/3
Ifosfamide injection1/14 (7)0/51/15 (7)3/12 (25)1/4 (25)
Mercaptopurine tablet0/140/52/14 (14)3/14 (21)1/7 (14)
Methotrexate tablet0/140/53/13 (23)4/13 (31)0/7
Methotrexate injection0/140/51/15 (7)2/14 (14)0/7
Thioguanine tablet1/11 (9)0/43/11 (27)4/5 (80)0/1
Vinblastine injection1/14 (7)0/53/15 (20)4/11 (36)1/6 (17)
Vincristine injection1/14 (7)0/52/15 (13)3/14 (21)1/7 (14)
SIOP ancillary
13-cis retinoic acid tablet/capsule2/12 (17)0/44/11 (36)3/5 (60)0/1
All-trans retinoic acid capsule2/13 (15)0/44/13 (31)3/8 (38)2/4 (50)
Busulphan tablet2/5 (40)0/25/9 (56)1/3 (33)
Imatinib tablet1/14 (7)0/54/15 (27)4/10 (40)1/6 (17)
Irinotecan injection1/14 (7)1/5 (20)3/14 (21)2/5 (40)0/2
Melphalan tablet1/6 (17)0/22/7 (29)2/5 (40)1/2 (50)
Topotecan injection1/14 (7)0/53/12 (25)3/5 (60)0/1
Vinorelbine injection2/14 (14)0/32/13 (15)3/6 (50)0/1
Other WHO EMLc
Calcium folinate (leucovorin) inject1/13 (8)0/52/15 (13)1/11 (9)0/7
Calcium folinate (leucovorin) tablet1/12 (8)0/44/13 (31)2/5 (40)1/5 (20)
Filgrastim injection1/13 (8)0/51/15 (7)1/10 (10)0/4
Mesna tablet1/6 (17)0/33/6 (50)
Mesna injection1/14 (7)0/51/15 (7)4/13 (31)0/4
  • *Only facilities reporting that the medicine is used are included in the denominator for calculation of %.

  • EMLc, Essential Medicines for Children; HIC, high-income country; LIC, low-income country; LMC, lower-middle-income country; SIOP, International Society of Paediatric Oncology ; UMC, upper-middle-income country.